Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Optimizing whole brain radiotherapy dose and fractionation: Results from a prospective phase III trial (NCCTG N107C (Alliance)/CEC.3).

Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D.

Int J Radiat Oncol Biol Phys. 2019 Oct 22. pii: S0360-3016(19)33906-9. doi: 10.1016/j.ijrobp.2019.10.024. [Epub ahead of print]

PMID:
31654784
2.

The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy.

Laack NN, Pugh SL, Brown PD, Fox S, Wefel JS, Meyers C, Choucair A, Khuntia D, Suh JH, Roberge D, Wendland MM, Bruner D.

Neurooncol Pract. 2019 Jul;6(4):274-282. doi: 10.1093/nop/npy038. Epub 2018 Dec 3.

PMID:
31386073
3.

Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA).

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu JB, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney NA, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Clin Transl Radiat Oncol. 2019 Jun 27;18:39-45. doi: 10.1016/j.ctro.2019.06.007. eCollection 2019 Sep.

4.

LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation.

Hartgerink D, Swinnen A, Roberge D, Nichol A, Zygmanski P, Yin FF, Deblois F, Hurkmans C, Ong CL, Bruynzeel A, Aizer A, Fiveash J, Kirckpatrick J, Guckenberger M, Andratschke N, de Ruysscher D, Popple R, Zindler J.

Acta Oncol. 2019 Sep;58(9):1275-1282. doi: 10.1080/0284186X.2019.1633016. Epub 2019 Jul 1.

PMID:
31257960
5.

Diagnostic Reliability of Leptomeningeal Disease Using Magnetic Resonance Imaging.

Harris P, Diouf A, Guilbert F, Ameur F, Letourneau-Guillon L, Ménard C, Masucci L, Bélair M, Roberge D.

Cureus. 2019 Apr 9;11(4):e4416. doi: 10.7759/cureus.4416.

6.

Risk-adapted stereotactic ablative radiotherapy for central and ultra-central lung tumours.

Lenglet A, Campeau MP, Mathieu D, Bahig H, Lambert L, Vu T, Roberge D, Bilodeau L, Filion E.

Radiother Oncol. 2019 May;134:178-184. doi: 10.1016/j.radonc.2019.01.035. Epub 2019 Feb 18.

PMID:
31005213
7.

Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu J, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney N, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Transl Res. 2019 Jun;208:63-72. doi: 10.1016/j.trsl.2019.02.011. Epub 2019 Feb 27.

PMID:
30885538
8.

Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer.

Laurie SA, Banerji S, Blais N, Brule S, Cheema PK, Cheung P, Daaboul N, Hao D, Hirsh V, Juergens R, Laskin J, Leighl N, MacRae R, Nicholas G, Roberge D, Rothenstein J, Stewart DJ, Tsao MS.

Curr Oncol. 2019 Feb;26(1):e81-e93. doi: 10.3747/co.26.4116. Epub 2019 Feb 1.

9.

Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma.

Bahig H, Lapointe A, Bedwani S, de Guise J, Lambert L, Filion E, Roberge D, Létourneau-Guillon L, Blais D, Ng SP, Nguyen-Tan PF.

Eur J Radiol. 2019 Jan;110:1-6. doi: 10.1016/j.ejrad.2018.11.005. Epub 2018 Nov 5.

PMID:
30599844
10.

Deprescribing conversations: a closer look at prescriber-patient communication.

Turner JP, Richard C, Lussier MT, Lavoie ME, Farrell B, Roberge D, Tannenbaum C.

Ther Adv Drug Saf. 2018 Oct 20;9(12):687-698. doi: 10.1177/2042098618804490. eCollection 2018 Dec.

11.

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Neuro Oncol. 2018 Nov 12;20(12):1652-1660. doi: 10.1093/neuonc/noy099.

12.

Radiotherapy Immobilization Mask Molding Through the Use of 3D-Printed Head Models.

Pham QV, Lavallée AP, Foias A, Roberge D, Mitrou E, Wong P.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818809051. doi: 10.1177/1533033818809051.

13.

The Future Is Now-Prospective Study of Radiosurgery for More Than 4 Brain Metastases to Start in 2018!

Roberge D, Brown PD, Whitton A, O'Callaghan C, Leis A, Greenspoon J, Smith GL, Hu JJ, Nichol A, Winch C, Chan MD.

Front Oncol. 2018 Sep 13;8:380. doi: 10.3389/fonc.2018.00380. eCollection 2018.

14.

Central3D: A Computer Tool to Help Clinicians Differentiate Central and Peripheral Lung Tumors.

Mathieu D, Daoust VC, Campeau MP, Filion É, Bilodeau L, Bahig H, Roberge D, Lenglet A, Bedwani S.

Pract Radiat Oncol. 2019 Jan;9(1):e98-e102. doi: 10.1016/j.prro.2018.07.002. Epub 2018 Jul 18.

PMID:
30031220
15.

Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):845-853. doi: 10.1016/j.ijrobp.2018.04.006. Epub 2018 Apr 12.

PMID:
29976497
16.

In a Heartbeat: An Assessment of Dynamic Dose Variation to Cardiac Structures Using Dual Source Computed Tomography.

Bahig H, de Guise J, Vu T, Blais D, Chartrand-Lefebvre C, Nguyen NT, Lavertu S, Guay JP, Bedwani S, Roberge D.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):950-959. doi: 10.1016/j.ijrobp.2018.01.049. Epub 2018 Jan 31.

PMID:
29559290
17.

Procarbazine, lomustine and vincristine toxicity in low-grade gliomas.

Jutras G, Bélanger K, Letarte N, Adam JP, Roberge D, Lemieux B, Lemieux-Blanchard É, Masucci L, Ménard C, Bahary JP, Moumdjian R, Berthelet F, Florescu M.

Curr Oncol. 2018 Feb;25(1):e33-e39. doi: 10.3747/co.25.3680. Epub 2018 Feb 28.

18.

Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience.

Jumeau R, Delouya G, Roberge D, Donath D, Béliveau-Nadeau D, Campeau MP.

Dig Liver Dis. 2018 Apr;50(4):396-400. doi: 10.1016/j.dld.2017.12.013. Epub 2017 Dec 21.

PMID:
29326012
19.

Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).

Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):812-816. doi: 10.1016/j.ijrobp.2017.06.2454.

PMID:
29063850
20.

SRS versus WBRT for resected brain metastases - Authors' reply.

Roberge D, Brown P.

Lancet Oncol. 2017 Oct;18(10):e560. doi: 10.1016/S1470-2045(17)30703-9. No abstract available.

PMID:
28971819
21.

Helical Tomotherapy for Postmastectomy Radiotherapy after Immediate Left Breast Reconstruction: A Case Study.

Mathieu D, Shahvary N, Côté N, Boulva K, Meloche-Dumas L, Vu T, Patocskai E, Bernier C, Roberge D, Fortin I.

Cureus. 2017 Jul 12;9(7):e1462. doi: 10.7759/cureus.1462.

22.

Phase 1-2 Study of Dual-Energy Computed Tomography for Assessment of Pulmonary Function in Radiation Therapy Planning.

Bahig H, Campeau MP, Lapointe A, Bedwani S, Roberge D, de Guise J, Blais D, Vu T, Lambert L, Chartrand-Lefebvre C, Lord M, Filion E.

Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):334-343. doi: 10.1016/j.ijrobp.2017.05.051. Epub 2017 Jun 7.

PMID:
28871983
23.

The Treatment of Brain AVMs Study (TOBAS): an all-inclusive framework to integrate clinical care and research.

Magro E, Gentric JC, Batista AL, Kotowski M, Chaalala C, Roberge D, Weill A, Stapf C, Roy D, Bojanowski MW, Darsaut TE, Klink R, Raymond J.

J Neurosurg. 2018 Jun;128(6):1823-1829. doi: 10.3171/2017.2.JNS162751. Epub 2017 Sep 1.

PMID:
28862547
24.

The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.

Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1069-1077. doi: 10.1016/j.ijrobp.2017.03.030. Epub 2017 Mar 29.

PMID:
28721890
25.

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.

Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D.

Lancet Oncol. 2017 Aug;18(8):1049-1060. doi: 10.1016/S1470-2045(17)30441-2. Epub 2017 Jul 4.

26.

Explaining time elapsed prior to cancer diagnosis: patients' perspectives.

Brousselle A, Breton M, Benhadj L, Tremblay D, Provost S, Roberge D, Pineault R, Tousignant P.

BMC Health Serv Res. 2017 Jun 28;17(1):448. doi: 10.1186/s12913-017-2390-1.

27.

A dosimetric parameter to limit chest wall toxicity in SABR of NSCLC.

Jumeau R, Filion É, Bahig H, Vu T, Lambert L, Roberge D, Doucet R, Campeau MP.

Br J Radiol. 2017 Jul;90(1075):20170196. doi: 10.1259/bjr.20170196. Epub 2017 Jun 7.

28.

Larynx motion considerations in partial larynx volumetric modulated arc therapy for early glottic cancer.

Bahig H, Nguyen-Tan PF, Filion É, Roberge D, Thanomsack P, de Guise J, Blais D, Doucet R, Létourneau-Guillon L, Lambert L.

J Med Imaging Radiat Oncol. 2017 Oct;61(5):666-673. doi: 10.1111/1754-9485.12612. Epub 2017 May 30.

PMID:
28557310
29.

The Treatment of Brain Arteriovenous Malformation Study (TOBAS): A preliminary inter- and intra-rater agreement study on patient management.

Fahed R, Batista AL, Darsaut TE, Gentric JC, Ducroux C, Chaalala C, Roberge D, Bojanowski MW, Weill A, Roy D, Magro E, Raymond J.

J Neuroradiol. 2017 Jul;44(4):247-253. doi: 10.1016/j.neurad.2017.03.003. Epub 2017 Apr 26.

PMID:
28454721
30.

Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature.

Iskanderani O, Roberge D, Coulombe G.

Cureus. 2017 Mar 26;9(3):e1115. doi: 10.7759/cureus.1115.

31.

Efficiency of Crizotinib on an ALK-Positive Inflammatory Myofibroblastic Tumor of the Central Nervous System: A Case Report.

Chennouf A, Arslanian E, Roberge D, Berthelet F, Bojanowski M, Bahary JP, Masucci L, Belanger K, Florescu M, Wong P.

Cureus. 2017 Mar 2;9(3):e1068. doi: 10.7759/cureus.1068.

32.

Effects of interdisciplinary teamwork on patient-reported experience of cancer care.

Tremblay D, Roberge D, Touati N, Maunsell E, Berbiche D.

BMC Health Serv Res. 2017 Mar 20;17(1):218. doi: 10.1186/s12913-017-2166-7.

33.

Reproducibility of a Noninvasive System for Eye Positioning and Monitoring in Stereotactic Radiotherapy of Ocular Melanoma.

Iskanderani O, Béliveau-Nadeau D, Doucet R, Coulombe G, Pascale D, Roberge D.

Technol Cancer Res Treat. 2017 Jun;16(3):352-356. doi: 10.1177/1533034617690979. Epub 2017 Feb 7.

34.

The impacts of mid-treatment CBCT-guided patient repositioning on target coverage during lung VMAT.

Mathieu D, Campeau MP, Bedwani S, Roberge D, Doucet R, Zerouali K, Bahig H, Vu T, Lambert L, Masucci L, Filion E.

J Med Imaging Radiat Oncol. 2017 Aug;61(4):543-549. doi: 10.1111/1754-9485.12591. Epub 2017 Feb 7.

PMID:
28168813
35.

Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience.

Hijazi H, Campeau MP, Roberge D, Donath D, Lapointe R, Vandenbroucke-Menu F, Taussky D, Boudam K, Chan G, Bujold A, Delouya G.

Cureus. 2016 Dec 20;8(12):e935. doi: 10.7759/cureus.935.

36.

Assessing the performance of centralized waiting lists for patients without a regular family physician using clinical-administrative data.

Breton M, Smithman MA, Brousselle A, Loignon C, Touati N, Dubois CA, Nour K, Boivin A, Berbiche D, Roberge D.

BMC Fam Pract. 2017 Jan 5;18(1):1. doi: 10.1186/s12875-016-0573-1.

37.

Assessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma.

Jumeau R, Bahig H, Filion É, Campeau MP, Lambert L, Roberge D, Gorgos AB, Vu T.

Cureus. 2016 Nov 29;8(11):e901. doi: 10.7759/cureus.901.

38.

Localization of ectopic fibroblast growth factor 23 production in tumor-induced osteomalacia using selective venous samplings.

Pelletier K, Troyanov S, Guité JF, Sainte-Marie LG, Roberge D, Lessard M.

Clin Nephrol. 2017 Feb;87 (2017)(2):107-110. doi: 10.5414/CN108981. No abstract available.

PMID:
28025958
39.

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).

Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP.

JAMA Oncol. 2017 Jun 1;3(6):827-831. doi: 10.1001/jamaoncol.2016.3834.

40.

The Use of Molecular Oxygen in Pharmaceutical Manufacturing: Is Flow the Way to Go?

Hone CA, Roberge DM, Kappe CO.

ChemSusChem. 2017 Jan 10;10(1):32-41. doi: 10.1002/cssc.201601321. Epub 2016 Nov 16.

PMID:
27863103
41.

A Study of Pseudoprogression After Spine Stereotactic Body Radiation Therapy.

Bahig H, Simard D, Létourneau L, Wong P, Roberge D, Filion E, Donath D, Sahgal A, Masucci L.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):848-856. doi: 10.1016/j.ijrobp.2016.07.034. Epub 2016 Jul 30.

PMID:
27788956
42.

Continuous Flow Homolytic Aromatic Substitution with Electrophilic Radicals: A Fast and Scalable Protocol for Trifluoromethylation.

Monteiro JL, Carneiro PF, Elsner P, Roberge DM, Wuts PG, Kurjan KC, Gutmann B, Kappe CO.

Chemistry. 2017 Jan 1;23(1):176-186. doi: 10.1002/chem.201604579. Epub 2016 Dec 2.

PMID:
27775849
43.

Analysis of Pulmonary Vein Antrums Motion with Cardiac Contraction Using Dual-Source Computed Tomography.

Bahig H, de Guise J, Vu T, Chartrand-Lefebvre C, Blais D, Lebeau M, Nguyen NT, Roberge D.

Cureus. 2016 Jul 26;8(7):e712. doi: 10.7759/cureus.712.

44.

The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.

Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):406-413. doi: 10.1016/j.ijrobp.2016.06.006. Epub 2016 Jun 14.

45.

Primary Cutaneous B-Cell Lymphoma in Young Monozygotic Twins: A Case Report.

Bahig H, Petrogiannis-Haliotis T, Pehr KL, Roberge D.

J Cutan Med Surg. 2016 Nov;20(6):582-585. Epub 2016 Jun 29.

PMID:
27358311
46.

A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapy.

Wong P, Leppert IR, Roberge D, Boudam K, Brown PD, Muanza T, Pike GB, Chankowsky J, Mihalcioiu C.

Oncotarget. 2016 Aug 9;7(32):50986-50996. doi: 10.18632/oncotarget.9653.

47.

[Treatment of brain AVMS (TOBAS): A randomized controlled trial and registry].

Magro E, Gentric JC, Darsaut TE, Batista AL, Chaalala C, Roberge D, Weill A, Roy D, Bojanowski MW, Raymond J.

Neurochirurgie. 2016 Aug;62(4):197-202. doi: 10.1016/j.neuchi.2015.12.008. Epub 2016 May 25. French.

PMID:
27236732
48.

Technique for Robotic Stereotactic Irradiation of Choroidal Melanoma.

Béliveau-Nadeau D, Callejo S, Roberge D.

Cureus. 2016 Apr 21;8(4):e582. doi: 10.7759/cureus.582.

49.

Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases.

Bauman G, Yartsev S, Roberge D, MacRae R, Roa W, Panet-Raymond V, Masucci L, Yaremko B, D'Souza D, Palma D, Sexton T, Yu E, Pantarotto JR, Ahmad B, Fisher B, Dar AR, Lambert C, Pond G, Stitt L, Tay KY, Rodrigues G.

J Neurooncol. 2016 Jul;128(3):431-6. doi: 10.1007/s11060-016-2128-7. Epub 2016 Apr 15.

PMID:
27084705
50.

Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease.

Bahig H, Filion E, Vu T, Chalaoui J, Lambert L, Roberge D, Gagnon M, Fortin B, Béliveau-Nadeau D, Mathieu D, Campeau MP.

Pract Radiat Oncol. 2016 Sep-Oct;6(5):367-374. doi: 10.1016/j.prro.2016.01.009. Epub 2016 Jan 26.

PMID:
27068780

Supplemental Content

Loading ...
Support Center